regadenoson has been researched along with Liver Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biederman, RW; Dishart, MK; Doyle, M; Fakhri, AA; Grant, SB; Nathan, S; Oliva, J; Poydence, J; Reddy, ST; Shah, M; Singh, A; Thai, NL; Tom, KB; Williams, RB; Yamrozik, JA | 1 |
| Aljaroudi, W; Bhambhvani, P; Heo, J; Iqbal, F; Iskandrian, AE; Koneru, J | 1 |
1 trial(s) available for regadenoson and Liver Diseases
| Article | Year |
|---|---|
Safety of regadenoson in patients with end-stage liver disease.
Topics: Adenosine A2 Receptor Antagonists; Aged; Comorbidity; Coronary Artery Disease; Drug-Related Side Effects and Adverse Reactions; Exercise Test; Female; Humans; Liver Diseases; Male; Ohio; Purines; Pyrazoles; Radionuclide Imaging; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Terminally Ill; Vasodilator Agents | 2011 |
1 other study(ies) available for regadenoson and Liver Diseases
| Article | Year |
|---|---|
Exploratory use of cardiovascular magnetic resonance imaging in liver transplantation: a one-stop shop for preoperative cardiohepatic evaluation.
Topics: Adenosine; Adult; Cardiovascular Diseases; Contrast Media; Coronary Angiography; Dobutamine; Feasibility Studies; Female; Humans; Liver Diseases; Liver Transplantation; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Predictive Value of Tests; Preoperative Care; Purines; Pyrazoles | 2013 |